You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Preleukemia

Showing 1 - 25 of 1,230
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Preleukemia, MDS, Cytopenia Trial in Copenhagen (Metformin)

Recruiting
  • Preleukemia
  • +2 more
  • Copenhagen, Copenhagen N, Denmark
    Rigshospitalet
Jan 20, 2022

Biospecimen Acquisition for Myelodysplastic Syndromes

Recruiting
  • Myelodysplastic Syndromes
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 20, 2022

    MDS Trial (Fasting-mimicking diet (FMD) and physiotherapy)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Fasting-mimicking diet (FMD) and physiotherapy
    • (no location specified)
    Jun 22, 2022

    MDS Trial run by the National Cancer Institute (NCI) (decitabine and cedazuridine, BMS-986253)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 17, 2022

    MDS Trial (Hetrombopag)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • (no location specified)
    May 23, 2022

    MDS Trial (Yisui granule, Placebo)

    Not yet recruiting
    • MDS
    • Yisui granule
    • Placebo
    • (no location specified)
    Jan 13, 2023

    Interplay Between Immune and Metabolic Programs in

    Recruiting
    • Myelodysplastic Syndromes
      • Toulouse, France
        IUCT-Oncopole University Hospital
      May 17, 2022

      Mean Platelet Volume and Its Relation to Risk Stratification of

      Completed
      • Myelodysplastic Syndromes
        • (no location specified)
        Jan 21, 2022

        Acute Myeloid Leukemia, MDS Trial (Galinpepimut-S)

        Available
        • Acute Myeloid Leukemia
        • Myelodysplastic Syndromes
        • Galinpepimut-S
        • (no location specified)
        Oct 20, 2022

        Myelodysplastic Syndrome (MDS) Trial in Yamagata (ASTX030)

        Recruiting
        • Myelodysplastic Syndrome (MDS)
        • Yamagata, Japan
          Yamagata University Hospital
        Jun 20, 2022

        MDS Trial in Saint Louis (vosaroxin, Azacitidine)

        Active, not recruiting
        • Myelodysplastic Syndromes
        • Saint Louis, Missouri
          Washington University School of Medicine
        Mar 23, 2022

        Physical Activity in Transfusion Dependent Myelodysplastic

        Recruiting
        • Myelodysplastic Syndromes
        • Medical Device Usage and Evaluation
        • +3 more
        • Philadelphia, Pennsylvania
          Sidney Kimmel Cancer Center at Thomas Jefferson University
        Aug 16, 2022

        Minimisation Measures for REBLOZYL Among Healthcare

        Active, not recruiting
        • Myelodysplastic Syndromes
        • Beta-thalassemia
          • City, State, Austria
            Local Institution
          Aug 4, 2022

          Higher Risk Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial (AMG 176, Azacitidine)

          Not yet recruiting
          • Higher Risk Myelodysplastic Syndrome
          • Chronic Myelomonocytic Leukemia
          • (no location specified)
          Jul 29, 2022

          Low Risk MDS Trial (R906289 Monosodium (R289 Na))

          Not yet recruiting
          • Low Risk Myelodysplastic Syndromes
          • R906289 Monosodium (R289 Na)
          • (no location specified)
          Jul 22, 2022

          Relapsed / Refractory MDS Trial (NCR300)

          Not yet recruiting
          • Relapsed / Refractory Myelodysplastic Syndromes
          • (no location specified)
          May 7, 2022

          Myelodysplastic Syndrome Trial in New York (Revlimid (Lenalidomide))

          Active, not recruiting
          Has Results
          • Myelodysplastic Syndrome
          • Revlimid (Lenalidomide)
          • New York, New York
            Columbia University Medical Center
          Jan 12, 2022

          Clonal Cytopenia of Undetermined Significance, MDS Trial in Saint Louis (Atorvastatin, Rosuvastatin)

          Not yet recruiting
          • Clonal Cytopenia of Undetermined Significance
          • Myelodysplastic Syndromes
          • Saint Louis, Missouri
            Washington University School of Medicine
          Jul 28, 2022

          Myelodysplasia, Hematologic Malignancy Trial in Columbus (CliniMACS® TCRaß/CD19 Combined Depletion System)

          Recruiting
          • Myelodysplasia
          • Hematologic Malignancy
          • CliniMACS® TCRαβ/CD19 Combined Depletion System
          • Columbus, Ohio
            Nationwide Children's Hospital
          Jan 11, 2022

          MDS Trial (Pevonedistat, Azacitidine)

          No longer available
          • Myelodysplastic Syndromes
          • (no location specified)
          Sep 8, 2021

          MDS Trial in Houston (Sertraline, Bone Marrow Aspirate/Biopsy)

          Terminated
          • Myelodysplastic Syndromes
          • Houston, Texas
          • +1 more
          May 31, 2022

          MDS, Acute Myeloid Leukemia Trial (Sabatolimab, Magrolimab, Azacitidine)

          Not yet recruiting
          • Myelodysplastic Syndromes
          • Acute Myeloid Leukemia
          • (no location specified)
          May 24, 2022

          High Risk Myelodysplastic Syndrome Trial in Houston (Guadecitabine)

          Active, not recruiting
          • High Risk Myelodysplastic Syndrome
          • Houston, Texas
            M D Anderson Cancer Center
          Feb 2, 2022

          High Grade MDS Trial in Aurora (Omacetaxine, Azacitidine)

          Recruiting
          • High Grade Myelodysplastic Syndromes
          • Aurora, Colorado
            Universtiy of Colorado Denver
          Oct 19, 2021

          Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS), Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Trial

          Not yet recruiting
          • Acute Myeloid Leukaemia (AML)
          • +2 more
          • (no location specified)
          Sep 6, 2022